Prescription opioid abuse in prison settings: A systematic review of prevalence, practice and treatment responses

Zanib Bi-Mohammed, Nat M. Wright, Philippa Hearty, Nigel King, Helen Gavin

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

Background To systematically review the quantitative and qualitative evidence base pertaining to the prevalence, practice of, and treatment response to the diversion of prescribed opiates in the prison setting. Methods Medline, Embase, CINAHL, PsycINFO, Google Scholar, ASSIA and Science Direct databases were searched for papers from 1995 to the present relevant to the abuse of prescribed opiate medication. Identified journals and their reference lists were hand searched for other relevant articles. Of the abstracts identified as relevant, full text papers were retrieved and critiqued against the inclusion criteria for the review. Results Three hundred and fifty-five abstracts were identified, leading to 42 full-text articles being retrieved. Of those, 10 papers were included in the review. Significant differences in abuse behaviours between different countries were reported. However, a key theme emerged from the data regarding a culture of nasal administration of prescribed sublingual buprenorphine within some prisons due to both reduced prevalence of injection within prison and reduced supplies of illicit drugs within prison. The buprenorphine/naloxone preparation appears to be less amenable to abuse. The review highlighted a paucity of empirical research pertaining to both prevalence of the phenomenon and treatment responses. Clinical and research implications Healthcare providers within prisons need to prescribe opioids in the least abuseable preparation since the risk of abuse is significant, despite widespread processes of supervised dispensing. Prescription medication abuse is not limited to opioids and the predominant drug of abuse in an individual prison can rapidly change according to availability.

LanguageEnglish
Pages122-131
Number of pages10
JournalDrug and Alcohol Dependence
Volume171
DOIs
Publication statusPublished - 1 Feb 2017

Fingerprint

Prisons
Opioid Analgesics
Prescriptions
Opiate Alkaloids
Street Drugs
Therapeutics
Intranasal Administration
Buprenorphine
Empirical Research
Health Personnel
Availability
Databases
Injections
Research

Cite this

@article{c075324d7f284722af8e136c9c5a571e,
title = "Prescription opioid abuse in prison settings: A systematic review of prevalence, practice and treatment responses",
abstract = "Background To systematically review the quantitative and qualitative evidence base pertaining to the prevalence, practice of, and treatment response to the diversion of prescribed opiates in the prison setting. Methods Medline, Embase, CINAHL, PsycINFO, Google Scholar, ASSIA and Science Direct databases were searched for papers from 1995 to the present relevant to the abuse of prescribed opiate medication. Identified journals and their reference lists were hand searched for other relevant articles. Of the abstracts identified as relevant, full text papers were retrieved and critiqued against the inclusion criteria for the review. Results Three hundred and fifty-five abstracts were identified, leading to 42 full-text articles being retrieved. Of those, 10 papers were included in the review. Significant differences in abuse behaviours between different countries were reported. However, a key theme emerged from the data regarding a culture of nasal administration of prescribed sublingual buprenorphine within some prisons due to both reduced prevalence of injection within prison and reduced supplies of illicit drugs within prison. The buprenorphine/naloxone preparation appears to be less amenable to abuse. The review highlighted a paucity of empirical research pertaining to both prevalence of the phenomenon and treatment responses. Clinical and research implications Healthcare providers within prisons need to prescribe opioids in the least abuseable preparation since the risk of abuse is significant, despite widespread processes of supervised dispensing. Prescription medication abuse is not limited to opioids and the predominant drug of abuse in an individual prison can rapidly change according to availability.",
keywords = "Abuse, Abuse of prescribed medication, Buprenorphine, Buprenorphine/Naloxone, Diversion, Methadone, Misuse, Opioid, Oxycodone, OxyContin, Prison, Prisoner",
author = "Zanib Bi-Mohammed and Wright, {Nat M.} and Philippa Hearty and Nigel King and Helen Gavin",
year = "2017",
month = "2",
day = "1",
doi = "10.1016/j.drugalcdep.2016.11.032",
language = "English",
volume = "171",
pages = "122--131",
journal = "Drug and Alcohol Dependence",
issn = "0376-8716",
publisher = "Elsevier Ireland Ltd",

}

Prescription opioid abuse in prison settings : A systematic review of prevalence, practice and treatment responses. / Bi-Mohammed, Zanib; Wright, Nat M.; Hearty, Philippa; King, Nigel; Gavin, Helen.

In: Drug and Alcohol Dependence, Vol. 171, 01.02.2017, p. 122-131.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Prescription opioid abuse in prison settings

T2 - Drug and Alcohol Dependence

AU - Bi-Mohammed, Zanib

AU - Wright, Nat M.

AU - Hearty, Philippa

AU - King, Nigel

AU - Gavin, Helen

PY - 2017/2/1

Y1 - 2017/2/1

N2 - Background To systematically review the quantitative and qualitative evidence base pertaining to the prevalence, practice of, and treatment response to the diversion of prescribed opiates in the prison setting. Methods Medline, Embase, CINAHL, PsycINFO, Google Scholar, ASSIA and Science Direct databases were searched for papers from 1995 to the present relevant to the abuse of prescribed opiate medication. Identified journals and their reference lists were hand searched for other relevant articles. Of the abstracts identified as relevant, full text papers were retrieved and critiqued against the inclusion criteria for the review. Results Three hundred and fifty-five abstracts were identified, leading to 42 full-text articles being retrieved. Of those, 10 papers were included in the review. Significant differences in abuse behaviours between different countries were reported. However, a key theme emerged from the data regarding a culture of nasal administration of prescribed sublingual buprenorphine within some prisons due to both reduced prevalence of injection within prison and reduced supplies of illicit drugs within prison. The buprenorphine/naloxone preparation appears to be less amenable to abuse. The review highlighted a paucity of empirical research pertaining to both prevalence of the phenomenon and treatment responses. Clinical and research implications Healthcare providers within prisons need to prescribe opioids in the least abuseable preparation since the risk of abuse is significant, despite widespread processes of supervised dispensing. Prescription medication abuse is not limited to opioids and the predominant drug of abuse in an individual prison can rapidly change according to availability.

AB - Background To systematically review the quantitative and qualitative evidence base pertaining to the prevalence, practice of, and treatment response to the diversion of prescribed opiates in the prison setting. Methods Medline, Embase, CINAHL, PsycINFO, Google Scholar, ASSIA and Science Direct databases were searched for papers from 1995 to the present relevant to the abuse of prescribed opiate medication. Identified journals and their reference lists were hand searched for other relevant articles. Of the abstracts identified as relevant, full text papers were retrieved and critiqued against the inclusion criteria for the review. Results Three hundred and fifty-five abstracts were identified, leading to 42 full-text articles being retrieved. Of those, 10 papers were included in the review. Significant differences in abuse behaviours between different countries were reported. However, a key theme emerged from the data regarding a culture of nasal administration of prescribed sublingual buprenorphine within some prisons due to both reduced prevalence of injection within prison and reduced supplies of illicit drugs within prison. The buprenorphine/naloxone preparation appears to be less amenable to abuse. The review highlighted a paucity of empirical research pertaining to both prevalence of the phenomenon and treatment responses. Clinical and research implications Healthcare providers within prisons need to prescribe opioids in the least abuseable preparation since the risk of abuse is significant, despite widespread processes of supervised dispensing. Prescription medication abuse is not limited to opioids and the predominant drug of abuse in an individual prison can rapidly change according to availability.

KW - Abuse

KW - Abuse of prescribed medication

KW - Buprenorphine

KW - Buprenorphine/Naloxone

KW - Diversion

KW - Methadone

KW - Misuse

KW - Opioid

KW - Oxycodone

KW - OxyContin

KW - Prison

KW - Prisoner

UR - http://www.scopus.com/inward/record.url?scp=85009126861&partnerID=8YFLogxK

U2 - 10.1016/j.drugalcdep.2016.11.032

DO - 10.1016/j.drugalcdep.2016.11.032

M3 - Review article

VL - 171

SP - 122

EP - 131

JO - Drug and Alcohol Dependence

JF - Drug and Alcohol Dependence

SN - 0376-8716

ER -